메뉴 건너뛰기




Volumn 131, Issue 6, 2001, Pages 795-796

Pseudomonas aeruginosa in vitro corneal isolate sensitivity to ofloxacin, ciprofloxacin, and trovafloxacin: A comparative study

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

EID: 0035015389     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00896-5     Document Type: Article
Times cited : (4)

References (5)
  • 1
    • 0032880618 scopus 로고    scopus 로고
    • Emerging ciprofloxacin-resistant Pseudomonas aeruginosa
    • Chaudhry NA, Flynn HW Jr, Murray TG, et al. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol 1999;128:509-510.
    • (1999) Am J Ophthalmol , vol.128 , pp. 509-510
    • Chaudhry, N.A.1    Flynn Jr., H.W.2    Murray, T.G.3
  • 2
    • 0033498181 scopus 로고    scopus 로고
    • Ciprofloxacin-resistant Pseudomonas keratitis
    • Garg P, Sharma S, Rao GN. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 1999;106:1319-1323.
    • (1999) Ophthalmology , vol.106 , pp. 1319-1323
    • Garg, P.1    Sharma, S.2    Rao, G.N.3
  • 3
    • 0033511289 scopus 로고    scopus 로고
    • Emerging fluoroquinolone resistance in bacterial keratitis. A 5-year review
    • Goldse in MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis. A 5-year review. Ophthalmology 1999;106:1313-1318.
    • (1999) Ophthalmology , vol.106 , pp. 1313-1318
    • Goldse, M.H.1    Kowalski, R.P.2    Gordon, Y.J.3
  • 4
    • 0032622304 scopus 로고    scopus 로고
    • In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance
    • Kunimoto DY, Sharma S, Garg P, et al. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmology 1999;106:80-85.
    • (1999) Ophthalmology , vol.106 , pp. 80-85
    • Kunimoto, D.Y.1    Sharma, S.2    Garg, P.3
  • 5
    • 1842414243 scopus 로고    scopus 로고
    • In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram- Positive and gram-negative pathogens from respiratory tract infections
    • Hoogkamp-Korstanje JAA. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram- positive and gram-negative pathogens from respiratory tract infections. J Antimicrob Chemother 1997;40:427-431.
    • (1997) J Antimicrob Chemother , vol.40 , pp. 427-431
    • Hoogkamp-Korstanje, J.A.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.